| Title : AZ12756122, a novel fatty acid synthase inhibitor, decreases resistance features in EGFR-TKI resistant EGFR-mutated NSCLC cell models - Polonio-Alcala_2022_Biomed.Pharmacother_156_113942 |
| Author(s) : Polonio-Alcala E , Porta R , Ruiz-Martinez S , Vasquez-Dongo C , Relat J , Bosch-Barrera J , Ciurana J , Puig T |
| Ref : Biomed Pharmacother , 156 :113942 , 2022 |
| Abstract : Polonio-Alcala_2022_Biomed.Pharmacother_156_113942 |
| ESTHER : Polonio-Alcala_2022_Biomed.Pharmacother_156_113942 |
| PubMedSearch : Polonio-Alcala_2022_Biomed.Pharmacother_156_113942 |
| PubMedID: 36411628 |
Polonio-Alcala E, Porta R, Ruiz-Martinez S, Vasquez-Dongo C, Relat J, Bosch-Barrera J, Ciurana J, Puig T (2022)
AZ12756122, a novel fatty acid synthase inhibitor, decreases resistance features in EGFR-TKI resistant EGFR-mutated NSCLC cell models
Biomed Pharmacother
156 :113942
Polonio-Alcala E, Porta R, Ruiz-Martinez S, Vasquez-Dongo C, Relat J, Bosch-Barrera J, Ciurana J, Puig T (2022)
Biomed Pharmacother
156 :113942